CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
(XCM)+(CAF) +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04082130
NCT04082130N/ACompleted

Clinical Comparison of Coronally-advanced Flap Plus Xenogeneic Collagen Matrix (Fibro-Gide®) and Subepithelial Connective Tissue Graft in the Treatment of Gingival Recessions

Damascus University·interventional·Posted Sep 9, 2019·Updated Jan 12, 2021

In Brief

A clinical study evaluating (XCM)+(CAF) and (SCTG)+(CAF) for Gingival Recession Localized Moderate. Completed, enrolled 15 participants across 1 site.

Detailed Summary

this study is a Clinical evaluation of using Xenogenic collagen matrix (XCM) plus coronally advanced flap (CAF) compared to subepithelial connective tissue graft (SCTG) plus coronally advanced flap to treat Miller class I gingival recession. A split-full-split thickness flap will be elevated in the (XCM+CAF) group while it will be an only partial thickness flap in the (SCTG+CAF) group. The sample size will be 15 patients. Each patient has bilateral Miller Class I gingival recessions; and as a split-mouth study design one side will be treated with (SCTG+CAF), while the other will be treated with (XCM+CAF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSyria
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 9, 2019
Enrollment StartAug 25, 2019
Primary CompletionJun 30, 2020
Study CompletionAug 1, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.8 years ago

Interventions

(XCM)+(CAF)procedure

The description of this intervention has been already given before.

(SCTG)+(CAF)procedure

The description of this intervention has been already given before.